Goldman Sachs Reiterates Buy Rating on Amgen (AMGN)

November 25, 2025 5:07 AM EST Send to a Friend
Goldman Sachs analyst Salveen Richter reiterated a Buy rating and $400.00 price target on Amgen (NASDAQ: AMGN).The analyst comments "AMGN ...

This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE

Member Login